FEATURES OF CLINICAL COURSE AND MORPHOMETRIC PARAMETERS OF BENIGN PROSTATIC HYPERPLASIA IN MEN WITH METABOLIC SYNDROME AND ANDROGEN DEFICIENCY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The study was aimed to the evaluation of the effect of the components of the metabolic syndrome (obesity, insulin resistance (IR)) and androgen deficiency on the clinical course of lower urinary tract symptoms against the background of benign prostatic hyperplasia (LUTS/BPH) and nocturia, as well as on some of the parameters of BPH (prostate volume, residual urine volume, total prostate-specific antigen (PSA) blood level). The comprehensive survey of 160 men with LUTS/BPH (mean age 56.7±3.3 years) was performed; based on the results of survey, three comparison groups were formed: Group 1 (n=70) - patients with isolated obesity; Group 2 (n=36) - patients with obesity and insulin resistance; and Group 3 (n=54) - patients with obesity, insulin resistance and androgen deficiency. The control group consisted of 30 patients with LUTS/ BPH without these metabolic and hormonal disorders. In patients with LUTS/BPH and obesity, higher frequency of nocturia compared with the control group was revealed (63.7% vs 23.3%; P<0.05), as well as the relationship between the waist circumference and free testosterone level (n=160; r=-0.322; P=0.005) and waist circumference and total prostate volume (n=160; r=0.121; P=0.005). In patients of Group 2, significant positive correlation between waist circumference and blood insulin level was identified (n=36; r=0.461; P=0.005). Patients with obesity, insulin resistance and androgen deficiency had the highest average prostate volume and residual urine volume compared with those of other groups (P<0.05). Thus, obesity, insulin resistance, androgen deficiency are associated pathological conditions, greatly aggravating the clinical course of LUTS/BPH due to adverse impact on the BPH parameters, acting both together and separately. The most severe LUTS/BPH were associated with the presence of all three of the above systemic disorders.

Full Text

Restricted Access

About the authors

I. A Tyuzikov

Professor Kalinchenko Clinic

Email: phoenix-67@list.ru
Moscow

E. A Grekov

Professor Kalinchenko Clinic

Moscow

S. Yu Kalinchenko

Professor Kalinchenko Clinic; PFUR

PhD in Medical Sciences, professor; Honored Worker of Science and Education, Consultant at the Professor Moscow

References

  1. Gorbachinsky I., Akpinar H., Assimos D.G. Metabolic syndrome and urological diseases. Rev. Urol. 2010;12(4):157-180.
  2. Yassin A.A., El-Sakka A.I., Saad F. Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia. 2008;40:259-264.
  3. Калинченко С.Ю., Тюзиков И.А. Заболевания предстательной железы и метаболический синдром: новая патогенетическая концепция (литературный обзор). Медицинский алфавит. Больница. 2011;4:38-43.
  4. Kalyani R.R., Dobs A.S. Androgen deficiency, diabetes and the metabolic syndrome in men.Curr. Opin. Endocrinol. DiabetesObes. 2007;14:226-234.
  5. Калинченко С.Ю., Тюзиков И.А., Ворслов О.Л., Фомин А.М., Тишова Ю.А., Греков Е.А. Бессимптомная доброкачественная гиперплазия предстательной железы: лечить или не лечить? Эффективная фармакотерапия. Урология. 2012;4:20-22.
  6. Stellato R.K., Feldman H.A., Hamdy O. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000;23:490-494.
  7. Traish A.M., Miner M.M., Morgentaler A., Zitzmann M. Testosterone deficiency. Am J Med. 2011;124(7):578-587.
  8. McHenry Martin C. Testosterone deficiency in older men: a problem worth treating. Consult Pharm. 2012;27(3):152-163.
  9. Corona G., Monami M., Rastrelli G., Aversa A., Tishova Y., Saad F., Lenzi A., Forti G., Mannucci E., Maggi M. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011;8(1):272-283.
  10. DiBello J.R., Ioannou C., Rees J., Challacombe B., Maskell J., Choudhury N., Kastner C., Kirby M. The prevalence of metabolicsyndrome and its components amongst men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study. BJU Int. 2015 Sep 22.
  11. Ryl A., Rotter I., Slojewski M., Dolegowska B., Grabowska M., Baranowska-Bosiacka I., Laszczynska M. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosteronedeficiencysyndrome. Folia HistochemCytobiol. 2015 Sep 24.
  12. He Q., Wang Z., Liu G., Daneshgari F., MacLennan G.T., Gupta S. Metabolicsyndrome, inflammation and lower urinary tract symptoms: possible translational links.Prostate Cancer Prostatic Dis. 2015 Sep 22.
  13. Doğan Y., Uruç F., Aras B., Şahin A.,Kivrak M., Ürkmez A., Güner N.D., Aydin S. The relationships between metabolicsyndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia. Turk J Urol. 2015;41(1):7-12.
  14. Zou C., Gong D., Fang N., Fan Y. Meta-analysis of metabolicsyndrome and benign prostatic hyperplasia in Chinese patients. World J Urol. 2015. Jun 29.
  15. Jockenhovel F. Male hyрogonadism. auflage-bremen. Uni-Med. 2004. 185 р.
  16. Dohle G.R., Arver S., Bettocchi C. et al. Guidelines on Male Hypogonadism. EAU. 2015. 24 р.
  17. Lunenfeld B., Saad F., Hoesl C.E. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Aging Male. 2005;8(2):59-74.
  18. Azadzoi K.M., Tarcan T., Siroky M.B., Krane R.J. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and noncompliance in the rabbits. J. Urol. 1999;161:1626-1635.
  19. Demir O., Akgul K., Akar Z. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male. 2009;12:29-34.
  20. Koritsiadis G., Stravodimos K., Mitropoulos D. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study. BJU Int. 2008;101:1542-1546.
  21. Kozlowski R., Kershen R.T., Siroky M.B. Chronic ischemia alters prostate structure and reactivity in rabbits. J. Urol. 2001;165:1019-1026.
  22. Kupelian V., McVary K.T., Kaplan S.A. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J. Urol. 2009;182:616-624.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies